Apnimed, Inc. (APMD) SEC filings
APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 13, 2026
$16.92+0.29 (+1.74%)
Close on Nov 13, 2026Market cap $81.25MP/E –Yield –
SEC filings
5 of Apnimed's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report, amended | 10-Q/A | Jun 30, 2026 | Nov 13, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2026 | Nov 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
See a number that looks wrong?